Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Bacillus thuringiensis (Bt) vegetables will likely be commercialized in India soon. The technology could reduce pesticide residues in foods. Yet it is unclear whether consumers will appreciate this health advantage, or whether potential GM crop risks will dominate their attitudes. Using contingent valuation methods and a sample of urban households, we find that almost 60% of consumers would purchase Bt vegetables at current conventional vegetable prices, indicating a high acceptance level. The rest would purchase at a certain price discount. Strikingly, the required discount increases for people particularly concerned about pesticide residues, demonstrating that risk-averse consumers do not easily offset technology benefits against perceived risks.S ince the commercialization of the first genetically modified (GM) crops in the mid 1990s, biotechnology has remained one of the most controversial topics in agricultural sciences. There is a consensus among researchers that biotechnology applications can contribute to higher crop yields and improved food quality with environmentally friendly agronomic practices. Indeed, significant productivity increases and pesticide reductions have already been demonstrated in several countries (Fernandez-Cornejo and Caswell; Qaim). At the same time, critics remain suspicious about the wider impacts of agricultural biotechnology. GM food crops are argued to be associated with health risks for consumers, as newly introduced proteins could act as allergens or toxins and alter the metabolism of the crop (Altieri and Rosset). In addition, there are environmental, social, and ethical concerns (Ervin et al.; Welsh and Ervin; Greenpeace). Consumer concerns and risk perceptions have emerged as important driving forces of biotechnology policies in developed countries (Moon and Balasubramanian; Foreman). For
Bacillus thuringiensis (Bt) vegetables will likely be commercialized in India soon. The technology could reduce pesticide residues in foods. Yet it is unclear whether consumers will appreciate this health advantage, or whether potential GM crop risks will dominate their attitudes. Using contingent valuation methods and a sample of urban households, we find that almost 60% of consumers would purchase Bt vegetables at current conventional vegetable prices, indicating a high acceptance level. The rest would purchase at a certain price discount. Strikingly, the required discount increases for people particularly concerned about pesticide residues, demonstrating that risk-averse consumers do not easily offset technology benefits against perceived risks.S ince the commercialization of the first genetically modified (GM) crops in the mid 1990s, biotechnology has remained one of the most controversial topics in agricultural sciences. There is a consensus among researchers that biotechnology applications can contribute to higher crop yields and improved food quality with environmentally friendly agronomic practices. Indeed, significant productivity increases and pesticide reductions have already been demonstrated in several countries (Fernandez-Cornejo and Caswell; Qaim). At the same time, critics remain suspicious about the wider impacts of agricultural biotechnology. GM food crops are argued to be associated with health risks for consumers, as newly introduced proteins could act as allergens or toxins and alter the metabolism of the crop (Altieri and Rosset). In addition, there are environmental, social, and ethical concerns (Ervin et al.; Welsh and Ervin; Greenpeace). Consumer concerns and risk perceptions have emerged as important driving forces of biotechnology policies in developed countries (Moon and Balasubramanian; Foreman). For
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.